Your browser is no longer supported. Please, upgrade your browser.
Settings
ELGX Endologix, Inc. daily Stock Chart
ELGX [NASD]
Endologix, Inc.
Index- P/E- EPS (ttm)-7.45 Insider Own4.50% Shs Outstand17.64M Perf Week-15.15%
Market Cap101.78M Forward P/E- EPS next Y-2.27 Insider Trans9.30% Shs Float16.94M Perf Month-13.62%
Income-85.20M PEG- EPS next Q-0.72 Inst Own85.20% Short Float5.85% Perf Quarter-15.64%
Sales141.30M P/S0.72 EPS this Y-14.50% Inst Trans80.24% Short Ratio3.24 Perf Half Y6.03%
Book/sh3.97 P/B1.45 EPS next Y15.30% ROA-27.60% Target Price8.13 Perf Year-77.28%
Cash/sh2.89 P/C2.00 EPS next 5Y36.95% ROE-195.70% 52W Range5.20 - 26.50 Perf YTD-19.41%
Dividend- P/FCF- EPS past 5Y-28.70% ROI-26.80% 52W High-78.57% Beta0.42
Dividend %- Quick Ratio1.80 Sales past 5Y3.40% Gross Margin56.70% 52W Low9.31% ATR0.38
Employees528 Current Ratio2.50 Sales Q/Q-19.00% Oper. Margin-46.40% RSI (14)29.40 Volatility6.28% 6.16%
OptionableYes Debt/Eq0.00 EPS Q/Q47.10% Profit Margin-60.30% Rel Volume0.60 Prev Close5.77
ShortableYes LT Debt/Eq2.29 EarningsAug 08 AMC Payout- Avg Volume306.03K Price5.68
Recom- SMA20-12.53% SMA50-18.38% SMA200-19.99% Volume154,827 Change-1.56%
Aug-10-18Downgrade Piper Jaffray Overweight → Neutral
Jan-02-18Downgrade JP Morgan Neutral → Underweight
Dec-12-17Resumed Piper Jaffray Overweight
Nov-08-17Reiterated RBC Capital Mkts Sector Perform $5 → $4
May-18-17Downgrade Stifel Buy → Hold $10 → $5.50
Nov-17-16Downgrade Canaccord Genuity Buy → Hold $13.50 → $7.50
Nov-16-16Downgrade JP Morgan Overweight → Neutral
Sep-06-16Initiated Leerink Partners Mkt Perform
Aug-03-16Downgrade RBC Capital Mkts Outperform → Sector Perform $17 → $12
Jun-13-16Reiterated RBC Capital Mkts Outperform $15 → $17
May-10-16Reiterated RBC Capital Mkts Outperform $11 → $15
Apr-04-16Resumed JP Morgan Overweight
Feb-23-16Reiterated RBC Capital Mkts Outperform $15 → $11
Feb-02-16Reiterated Stifel Buy $17 → $15
Nov-17-15Reiterated RBC Capital Mkts Outperform $17 → $15
Oct-19-15Initiated RBC Capital Mkts Outperform $17
Aug-06-15Upgrade JP Morgan Neutral → Overweight $17
Aug-04-15Reiterated Stifel Buy $20 → $17
Apr-30-15Reiterated Oppenheimer Perform $15 → $17
Apr-06-15Reiterated Stifel Buy $17 → $20
Aug-13-19 01:35PM  Health Check: How Prudently Does Endologix (NASDAQ:ELGX) Use Debt? Simply Wall St. +5.26%
12:28AM  Edited Transcript of ELGX earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-19 05:15PM  Endologix (ELGX) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM  Endologix Announces Exclusive Distributor Agreement with Boston Scientific for the Chinese Market Business Wire
04:03PM  Endologix Receives IDE Approval for the Nellix Chimney EndoVascular Aneurysm Sealing Protocol Business Wire
04:01PM  Endologix Reports Second Quarter 2019 Financial Results Business Wire
Aug-01-19 10:33AM  Will Endologix (ELGX) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-15-19 04:01PM  Endologix, Inc. to Announce Second Quarter 2019 Financial Results on August 8, 2019 Business Wire
Jul-11-19 04:01PM  Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire -6.74%
Jun-20-19 08:34AM  Endologix, Inc. (ELGX) Shares March Higher, Can It Continue? Zacks
06:29AM  Investors Who Bought Endologix (NASDAQ:ELGX) Shares Five Years Ago Are Now Down 95% Simply Wall St.
Jun-17-19 04:01PM  Endologix, Inc. to Present at the BMO Prescriptions for Success Healthcare Conference Business Wire
Jun-07-19 07:24AM  The Daily Biotech Pulse: Vertex Bets Big On Gene-Editing Therapies, Sanofi Poaches Novartis For CEO Role, Relief In Europe for Endologix Benzinga
Jun-06-19 04:01PM  Endologix Announces Reinstatement of CE Mark for its Nellix EndoVascular Aneurysm Sealing System Business Wire
May-13-19 09:50AM  Zacks.com featured highlights include: Avis, California Resources, Brinker, Endologix and Brookdale Zacks
May-10-19 07:43AM  5 Broker-Friendly Stocks to Combat Market Jitters Zacks
May-03-19 03:22PM  Edited Transcript of ELGX earnings conference call or presentation 2-May-19 8:30pm GMT Thomson Reuters StreetEvents
07:49AM  The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen Benzinga
May-02-19 05:25PM  Endologix (ELGX) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:18PM  Endologix: 1Q Earnings Snapshot Associated Press
04:01PM  Endologix Reports First Quarter 2019 Financial Results Business Wire
Apr-25-19 09:00AM  Endologix (ELGX) Upgraded to Strong Buy: Here's Why Zacks
Apr-15-19 04:01PM  Endologix, Inc. to Announce First Quarter 2019 Financial Results on May 2, 2019 Business Wire
12:58PM  5 Stocks to Profit From (Legal) Insider Buying Signals InvestorPlace
Apr-08-19 12:04PM  Weekly CFO Buys Highlight GuruFocus.com
Apr-03-19 07:15PM  Endologix Inc (ELGX) CEO and Director John Onopchenko Bought $199,999 of Shares GuruFocus.com
Apr-01-19 07:48AM  Endologix Inc (ELGX) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com +5.14%
07:30AM  Endologix Announces Equity Financing of $52 Million and Debt Restructuring Addressing 2020 Maturities and Financial Covenants Business Wire
Mar-20-19 04:01PM  Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Mar-06-19 07:39AM  The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split Benzinga -11.82%
Mar-05-19 04:01PM  Endologix Announces Approval of Reverse Stock Split Business Wire +8.62%
Mar-01-19 06:22AM  Edited Transcript of ELGX earnings conference call or presentation 25-Feb-19 9:30pm GMT Thomson Reuters StreetEvents +13.86%
Feb-27-19 10:00AM  What Should We Expect From Endologix, Inc.s (NASDAQ:ELGX) Earnings Over The Next Few Years? Simply Wall St.
Feb-25-19 04:01PM  Endologix Reports Fourth Quarter and Fiscal Year 2018 Financial Results Business Wire
02:30PM  Endologix, Inc. to Host Earnings Call ACCESSWIRE
Feb-22-19 09:48AM  All You Need to Know About Endologix (ELGX) Rating Upgrade to Buy Zacks
Feb-18-19 10:30AM  Endologix (ELGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Feb-11-19 04:01PM  Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire +5.38%
Feb-07-19 08:30AM  Report: Developing Opportunities within Micron Technology, Endologix, Group 1 Automotive, Dana, MACOM Technology Solutions, and Fred's Future Expectations, Projections Moving into 2019 GlobeNewswire -6.84%
Feb-06-19 10:41AM  WellCare Health (WCG) Q4 Earnings Beat Estimates, Soar Y/Y Zacks -14.81%
10:39AM  Humana's (HUM) Q4 Earnings Surpass Estimates, Improve Y/Y Zacks
Feb-05-19 09:22AM  Centene's (CNC) Earnings Top Estimates in Q4, Surge Y/Y Zacks
Jan-29-19 04:01PM  Endologix, Inc. to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on February 25, 2019 Business Wire
Jan-22-19 04:01PM  Endologix Provides Update on Previously Announced Voluntary Nellix System Recall Business Wire -9.63%
Jan-11-19 08:00AM  Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Jan-10-19 08:00AM  Endologix Appoints John D. Zehren as Chief Commercial Officer Business Wire
Jan-07-19 08:00AM  Endologix Announces Fourth Quarter and Full-Year 2018 Preliminary Financial Results and Provides 2019 Financial Guidance Business Wire +5.20%
Jan-04-19 08:30AM  Endologix Takes Decisive Action to Optimize Patient Outcomes by Ensuring Nellix System Used Only within Current Indications Business Wire -15.54%
Dec-21-18 11:15AM  What Kind Of Shareholder Owns Most Endologix, Inc. (NASDAQ:ELGX) Stock? Simply Wall St.
Dec-20-18 04:01PM  Endologix, Inc. to Present at the J.P. Morgan Healthcare Conference Business Wire
Dec-13-18 04:01PM  Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Nov-15-18 05:00PM  Endologix Honors Innovators of Aortic Therapy at VEITHsymposium Business Wire +7.53%
Nov-12-18 07:50AM  Report: Developing Opportunities within Mednax, Peabody Energy, NIC, Endologix, MobileIron, and QuinStreet Future Expectations, Projections Moving into 2018 GlobeNewswire -8.11%
Nov-08-18 04:01PM  Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire -5.26%
Nov-07-18 01:15AM  Edited Transcript of ELGX earnings conference call or presentation 1-Nov-18 8:30pm GMT Thomson Reuters StreetEvents
Nov-01-18 06:30PM  Endologix (ELGX) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:24PM  Endologix: 3Q Earnings Snapshot Associated Press
04:01PM  Endologix Reports Third Quarter 2018 Financial Results Business Wire
Oct-29-18 04:01PM  Endologix, Inc. to Present at Two Investor Conferences in November Business Wire
Oct-25-18 10:16AM  Endologix Announces Pricing of Public Offering of Common Stock Business Wire -14.75%
08:03AM  The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price Benzinga
Oct-24-18 04:01PM  Endologix Announces Public Offering of Common Stock Business Wire
Oct-22-18 04:01PM  Endologix, Inc. to Announce Third Quarter 2018 Financial Results on November 1, 2018 Business Wire -5.06%
Oct-18-18 08:20AM  Consolidated Research: 2018 Summary Expectations for Barnes & Noble, Boot Barn, Endologix, Pilgrim's Pride, OraSure Technologies, and Genesco Fundamental Analysis, Key Performance Indications GlobeNewswire
Oct-05-18 05:46PM  FDA Classifies Previous Endologix AFX Safety Notice as Class I Recall Business Wire -8.82%
Oct-03-18 07:54AM  The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares Benzinga
Oct-02-18 04:01PM  Endologix Announces Third Quarter Preliminary Revenue Results and Raises Low End of 2018 Revenue Guidance Range Business Wire
Aug-28-18 08:10AM  New Research Coverage Highlights MACOM Technology Solutions, Arrowhead Pharmaceuticals, PTC Therapeutics, Boot Barn, Darling Ingredients, and Endologix Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
08:05AM  Edited Transcript of ELGX earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-23-18 04:01PM  Endologix Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire -6.72%
08:00AM  Endologix to Host Investor Meeting on October 2, 2018 Business Wire
Aug-15-18 08:00AM  Endologix Appoints Jeffrey S. Brown as Chief Operations Officer Business Wire
Aug-10-18 06:03PM  Here's Why Endologix Plummeted 37% Today Motley Fool -36.92%
Aug-09-18 05:15PM  Endologix (ELGX) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:09PM  Endologix: 2Q Earnings Snapshot Associated Press
04:01PM  Endologix Reports Second Quarter 2018 Financial Results Business Wire
02:30PM  Endologix, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-18 05:06AM  3 Dental Stocks to Top Earnings Estimates This Season Zacks
Jul-31-18 07:31AM  Free Pre-Market Technical Recap on DENTSPLY SIRONA and Three Additional Medical Supplies Stocks ACCESSWIRE
Jul-16-18 04:01PM  Endologix, Inc. to Announce Second Quarter 2018 Financial Results on August 9, 2018 Business Wire
Jun-29-18 07:20AM  Free Technical Research on Valeritas Holdings and Three More Medical Supplies Equities ACCESSWIRE
Jun-28-18 08:10AM  Market Trends Toward New Normal in Endologix, Sanmina, First American Financial, Expeditors International of Washington, Liberty Broadband, and Nu Skin Enterprises Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
08:00AM  Endologix Reports Positive 1-Year Results from the Ovation® LUCY Study Business Wire
Jun-25-18 04:01PM  Endologix Appoints Jeffry Fecho as Chief Quality Officer Business Wire
Jun-07-18 11:06AM  What Is Endologix Incs (NASDAQ:ELGX) Share Price Doing? Simply Wall St.
May-29-18 07:00AM  Free Daily Technical Summary Reports on Endologix and Three Other Medical Supplies Stocks ACCESSWIRE
May-17-18 06:02PM  Edited Transcript of ELGX earnings conference call or presentation 2-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-15-18 08:25AM  Analysis: Positioning to Benefit within G-III Apparel Group, LTD, Diebold Nixdorf, Endologix, MACOM Technology Solutions, Halyard Health, and REV Group Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-02-18 07:17PM  Endologix: 1Q Earnings Snapshot Associated Press
04:15PM  Endologix Appoints John Onopchenko as Chief Executive Officer Business Wire
04:14PM  Endologix Reports First Quarter 2018 Financial Results Business Wire
Apr-25-18 10:00AM  Endovascular Aneurysm Sealing (EVAS) with Nellix System Associated with Higher Survival than Traditional Endovascular Aneurysm Repair (EVAR) in New Study Business Wire
Apr-10-18 08:15PM  Has Endologix Inc (NASDAQ:ELGX) Improved Earnings Growth In Recent Times? Simply Wall St.
Apr-03-18 04:01PM  Endologix, Inc. to Announce First Quarter 2018 Financial Results on May 2, 2018 Business Wire
Mar-19-18 04:01PM  Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems Business Wire
01:26PM  Will Endologix Incs (NASDAQ:ELGX) Earnings Grow In The Year Ahead? Simply Wall St.
Mar-05-18 08:00AM  Endologix, Inc. Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix® EndoVascular Aneurysm Sealing System Business Wire
07:50AM  Free Research Report as Haemonetics Revenues Grew 2.7% and Adjusted EPS Surged 44% ACCESSWIRE
Feb-28-18 02:51PM  What You Must Know About Endologix Incs (NASDAQ:ELGX) Financial Strength Simply Wall St.
Feb-22-18 12:10PM  Edited Transcript of ELGX earnings conference call or presentation 21-Feb-18 9:30pm GMT Thomson Reuters StreetEvents -7.65%
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALLER GREGORY DDirectorAug 14Sale6.617154,72629,922Aug 15 08:23 PM
Wilder ThomasDirectorAug 14Sale6.611,3699,04927,864Aug 15 08:22 PM
Wilder ThomasDirectorMay 07Sale6.341,4559,22415,739May 09 07:40 PM
Onopchenko JohnCEO and DirectorApr 03Buy6.6130,257199,99996,360Apr 03 04:19 PM
Mahboob VaseemChief Financial OfficerApr 03Buy6.6115,12899,99676,820Apr 03 04:16 PM
Zenty III Thomas FDirectorApr 03Buy6.613,02519,99522,053Apr 03 04:12 PM
NEELS GUIDO JDirectorApr 03Buy6.6122,692149,99443,200Apr 03 04:09 PM